Correction: Patient-derived organoids for precision oncology: a platform to facilitate clinical decision making
BMC Cancer(2023)
摘要
We report development of a novel integrated platform to facilitate clinical decision-making using the patient's primary cells, iPSCs and derivatives, to clinically relevant models for oncology research.
更多查看译文
关键词
Patient-Derived Organoids (PDOs),Tumor Microenvironment (TME),Patient-derived Xenograft (PDX),Drug efficacy and safety studies,Patient-derived induced pluripotent stem cells (iPSCs)
AI 理解论文
溯源树
样例
![](https://originalfileserver.aminer.cn/sys/aminer/pubs/mrt_preview.jpeg)
生成溯源树,研究论文发展脉络
Chat Paper
正在生成论文摘要